SynthesisBMC nephrology2026
Preventive efficacy of oxygen therapy against contrast-associated acute kidney injury in patients undergoing coronary angiography: a systematic review and meta-analysis of randomized controlled trials.
Synthesis in BMC nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionContrast‑associated acute kidney injury (CA-AKI) is a common and serious complication of coronary angiography. Supplemental oxygen therapy has been proposed as a simple strategy to reduce CA-AKI by improving renal oxygenation, but existing trial results are inconsistent. This systematic review and meta-analysis evaluated the efficacy of oxygen therapy in preventing CA-AKI among patients undergoing coronary angiography.
methodWe conducted a systematic review and meta-analysis in accordance with PRISMA guidelines, searching PubMed, Google Scholar, Scopus, Web of Science, and Embase from inception to December 2025. Studies evaluating post-angiography serum creatinine levels and the incidence of CA-AKI were included. Data were analyzed using random-effects models to account for between-study variability. Continuous outcomes were pooled as mean differences (SMDs) using the generic inverse variance method, while dichotomous outcomes were summarized as risk ratios (RRs). Heterogeneity among studies was assessed using the I² statistic,
resultWe screened 9,676 potential articles, and included five randomized controlled trials. Oxygenation therapy was associated with a significant reduction in serum creatinine levels at 48 h post-procedure, with a mean difference of - 0.10 mg/dL (95% CI - 0.16 to - 0.04; P = 0.001) and moderate heterogeneity among studies (I² = 61%). Additionally, the therapy significantly lowered the risk of CA-AKI, with a pooled risk ratio of 0.39 (95% CI 0.18-0.88; P = 0.02), although substantial heterogeneity was observed across trials (I² = 75%).
conclusionOxygenation therapy significantly reduces post-procedural serum creatinine levels and the risk of CA-AKI. Further large-scale randomized trials are warranted to confirm these findings given the observed heterogeneity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.